| 2 | The dimeric form of CXCL12 binds to atypical chemokine receptor 1. (Gutjahr JC, Crawford KS, Jensen DR, Naik P, Peterson FC, Samson GPB, Legler DF, Duchene J, Veldkamp CT, Rot A, Volkman BF) Sci Signal 2021 Aug 17;14(696) 9 Citations |
| 3 | Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. (Gao X, Qin S, Wu Y, Chu C, Jiang B, Johnson RH, Kuang D, Zhang J, Wang X, Mehta A, Tew KD, Leone GW, Yu XZ, Wang H) J Clin Invest 2021 Aug 16;131(16) 11 Citations |
| 1 | β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4. (D'Agostino G, Artinger M, Locati M, Perez L, Legler DF, Bianchi ME, Rüegg C, Thelen M, Marchese A, Rocchi MBL, Cecchinato V, Uguccioni M) Front Immunol 2020;11:550824 7 Citations |
| 3 | The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3. (Wedemeyer MJ, Mahn SA, Getschman AE, Crawford KS, Peterson FC, Marchese A, McCorvy JD, Volkman BF) J Biol Chem 2020 Oct 02;295(40):13927-13939 5 Citations |
| 1 | A non-GPCR-binding partner interacts with a novel surface on β-arrestin1 to mediate GPCR signaling. (Zhuo Y, Gurevich VV, Vishnivetskiy SA, Klug CS, Marchese A) J Biol Chem 2020 Oct 09;295(41):14111-14124 4 Citations |
| 1 | Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia-reperfusion injury and hemorrhage. (Babu FS, Liang X, Enten GA, DeSantis AJ, Volkman BF, Gao X, Majetschak M) Sci Rep 2020 Jul 09;10(1):11359 5 Citations |
| 2 | A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration. (Lau S, Feitzinger A, Venkiteswaran G, Wang J, Lewellis SW, Koplinski CA, Peterson FC, Volkman BF, Meier-Schellersheim M, Knaut H) Nat Cell Biol 2020 Mar;22(3):266-273 29 Citations |
| 1 | Heterologous regulation of CXCR4 lysosomal trafficking. (Caballero A, Mahn SA, Ali MS, Rogers MR, Marchese A) J Biol Chem 2019 May 17;294(20):8023-8036 10 Citations |
| 1 | Biased antagonism of CXCR4 avoids antagonist tolerance. (Hitchinson B, Eby JM, Gao X, Guite-Vinet F, Ziarek JJ, Abdelkarim H, Lee Y, Okamoto Y, Shikano S, Majetschak M, Heveker N, Volkman BF, Tarasova NI, Gaponenko V) Sci Signal 2018 Oct 16;11(552) 28 Citations |
| 1 | Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3. (Gao X, Abdelkarim H, Albee LJ, Volkman BF, Gaponenko V, Majetschak M) PLoS One 2018;13(9):e0204041 4 Citations |
| 1 | Endocytosis is required for CXC chemokine receptor type 4 (CXCR4)-mediated Akt activation and antiapoptotic signaling. (English EJ, Mahn SA, Marchese A) J Biol Chem 2018 Jul 20;293(29):11470-11480 24 Citations |
| 1 | Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex. (Gao X, Albee LJ, Volkman BF, Gaponenko V, Majetschak M) Sci Rep 2018 Feb 09;8(1):2730 14 Citations |
| 1 | Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3. (Szpakowska M, Nevins AM, Meyrath M, Rhainds D, D'huys T, Guité-Vinet F, Dupuis N, Gauthier PA, Counson M, Kleist A, St-Onge G, Hanson J, Schols D, Volkman BF, Heveker N, Chevigné A) Br J Pharmacol 2018 May;175(9):1419-1438 43 Citations |
| 1 | Detecting Cell Surface Expression of the G Protein-Coupled Receptor CXCR4. (Nevins AM, Marchese A) Methods Mol Biol 2018;1722:151-164 6 Citations |
| 1 | Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function. (Cheng YH, Eby JM, LaPorte HM, Volkman BF, Majetschak M) PLoS One 2017;12(11):e0187949 14 Citations |
| 1 | α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells. (Albee LJ, Eby JM, Tripathi A, LaPorte HM, Gao X, Volkman BF, Gaponenko V, Majetschak M) J Am Heart Assoc 2017 Aug 17;6(8) 26 Citations |
| 1 | Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists. (Eby JM, Abdelkarim H, Albee LJ, Tripathi A, Gao X, Volkman BF, Gaponenko V, Majetschak M) Mol Cell Biochem 2017 Oct;434(1-2):143-151 13 Citations |
| 3 | Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation. (Ziarek JJ, Kleist AB, London N, Raveh B, Montpas N, Bonneterre J, St-Onge G, DiCosmo-Ponticello CJ, Koplinski CA, Roy I, Stephens B, Thelen S, Veldkamp CT, Coffman FD, Cohen MC, Dwinell MB, Thelen M, Peterson FC, Heveker N, Volkman BF) Sci Signal 2017 Mar 21;10(471) 66 Citations |
| 1 | β-Arrestin1 and Signal-transducing Adaptor Molecule 1 (STAM1) Cooperate to Promote Focal Adhesion Kinase Autophosphorylation and Chemotaxis via the Chemokine Receptor CXCR4. (Alekhina O, Marchese A) J Biol Chem 2016 Dec 09;291(50):26083-26097 23 Citations |
| 1 | New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. (Evans AE, Tripathi A, LaPorte HM, Brueggemann LI, Singh AK, Albee LJ, Byron KL, Tarasova NI, Volkman BF, Cho TY, Gaponenko V, Majetschak M) Int J Mol Sci 2016 Jun 20;17(5) 28 Citations |
| 2 | Structure-Based Identification of Novel Ligands Targeting Multiple Sites within a Chemokine-G-Protein-Coupled-Receptor Interface. (Smith EW, Nevins AM, Qiao Z, Liu Y, Getschman AE, Vankayala SL, Kemp MT, Peterson FC, Li R, Volkman BF, Chen Y) J Med Chem 2016 May 12;59(9):4342-51 26 Citations |
| 1 | Monitoring Chemokine Receptor Trafficking by Confocal Immunofluorescence Microscopy. (Marchese A) Methods Enzymol 2016;570:281-92 5 Citations |
| 1 | Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function. (Tripathi A, Vana PG, Chavan TS, Brueggemann LI, Byron KL, Tarasova NI, Volkman BF, Gaponenko V, Majetschak M) Proc Natl Acad Sci U S A 2015 Mar 31;112(13):E1659-68 51 Citations |
| 1 | The endosomal sorting complex required for transport pathway mediates chemokine receptor CXCR4-promoted lysosomal degradation of the mammalian target of rapamycin antagonist DEPTOR. (Verma R, Marchese A) J Biol Chem 2015 Mar 13;290(11):6810-24 21 Citations |
| 2 | Structural analysis of a novel small molecule ligand bound to the CXCL12 chemokine. (Smith EW, Liu Y, Getschman AE, Peterson FC, Ziarek JJ, Li R, Volkman BF, Chen Y) J Med Chem 2014 Nov 26;57(22):9693-9 20 Citations |
| 1 | Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model. (Goodrich AD, Varain NM, Jeanblanc CM, Colon DM, Kim J, Zanjani ED, Hematti P) Cytotherapy 2014 Sep;16(9):1280-93 8 Citations |
| 1 | Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function. (Bach HH 4th, Wong YM, Tripathi A, Nevins AM, Gamelli RL, Volkman BF, Byron KL, Majetschak M) Mol Med 2014 Oct 13;20(1):435-47 29 Citations |
| 1 | The ubiquitin ligase deltex-3l regulates endosomal sorting of the G protein-coupled receptor CXCR4. (Holleman J, Marchese A) Mol Biol Cell 2014 Jun 15;25(12):1892-904 37 Citations |
| 1 | Endocytic trafficking of chemokine receptors. (Marchese A) Curr Opin Cell Biol 2014 Apr;27:72-7 76 Citations |
| 3 | CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. (Roy I, Zimmerman NP, Mackinnon AC, Tsai S, Evans DB, Dwinell MB) PLoS One 2014;9(3):e90400 65 Citations |
| 1 | The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1. (Guzzo C, Fox J, Lin Y, Miao H, Cimbro R, Volkman BF, Fauci AS, Lusso P) PLoS Pathog 2013;9(12):e1003852 29 Citations |
| 1 | CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1α and ubiquitin. (Tripathi A, Davis JD, Staren DM, Volkman BF, Majetschak M) Cytokine 2014 Feb;65(2):121-5 26 Citations |
| 1 | Genetics on a WHIM. (Al Ustwani O, Kurzrock R, Wetzler M) Br J Haematol 2014 Jan;164(1):15-23 38 Citations |
| 1 | Structure of the human glucagon class B G-protein-coupled receptor. (Siu FY, He M, de Graaf C, Han GW, Yang D, Zhang Z, Zhou C, Xu Q, Wacker D, Joseph JS, Liu W, Lau J, Cherezov V, Katritch V, Wang MW, Stevens RC) Nature 2013 Jul 25;499(7459):444-9 325 Citations |
| 1 | Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery. (Ziarek JJ, Getschman AE, Butler SJ, Taleski D, Stephens B, Kufareva I, Handel TM, Payne RJ, Volkman BF) ACS Chem Biol 2013 Sep 20;8(9):1955-63 45 Citations |
| 1 | Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib. (Stessman HA, Mansoor A, Zhan F, Janz S, Linden MA, Baughn LB, Van Ness B) Leukemia 2013 Oct;27(10):2075-7 41 Citations |
| 1 | Structure-based studies of chemokine receptors. (Zhu L, Zhao Q, Wu B) Curr Opin Struct Biol 2013 Aug;23(4):539-46 19 Citations |
| 2 | Modulation of the CXC chemokine receptor 4 agonist activity of ubiquitin through C-terminal protein modification. (Tripathi A, Saini V, Marchese A, Volkman BF, Tang WJ, Majetschak M) Biochemistry 2013 Jun 18;52(24):4184-92 18 Citations |
| 1 | Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. (Yu X, Lu C, Liu H, Rao S, Cai J, Liu S, Kriegel AJ, Greene AS, Liang M, Ding X) PLoS One 2013;8(5):e62703 75 Citations |
| 1 | Genome-wide search for the genes accountable for the induced resistance to HIV-1 infection in activated CD4+ T cells: apparent transcriptional signatures, co-expression networks and possible cellular processes. (Xu WW, Han MJ, Chen D, Chen L, Guo Y, Willden A, Liu DQ, Zhang HT) BMC Med Genomics 2013 May 01;6:15 20 Citations |
| 1 | CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis. (Takekoshi T, Wu X, Mitsui H, Tada Y, Kao MC, Sato S, Dwinell MB, Hwang ST) J Invest Dermatol 2013 Nov;133(11):2530-2537 16 Citations |
| 2 | Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction. (Ziarek JJ, Liu Y, Smith E, Zhang G, Peterson FC, Chen J, Yu Y, Chen Y, Volkman BF, Li R) Curr Top Med Chem 2012;12(24):2727-40 25 Citations |
| 1 | Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling. (Marchese A, Trejo J) Cell Signal 2013 Mar;25(3):707-16 69 Citations |
| 2 | Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus. (Ziarek JJ, Veldkamp CT, Zhang F, Murray NJ, Kartz GA, Liang X, Su J, Baker JE, Linhardt RJ, Volkman BF) J Biol Chem 2013 Jan 04;288(1):737-46 69 Citations |
| 1 | A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability. (Takekoshi T, Ziarek JJ, Volkman BF, Hwang ST) Mol Cancer Ther 2012 Nov;11(11):2516-25 47 Citations |
| 2 | Structure of the human κ-opioid receptor in complex with JDTic. (Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, Carroll FI, Mascarella SW, Westkaemper RB, Mosier PD, Roth BL, Cherezov V, Stevens RC) Nature 2012 Mar 21;485(7398):327-32 736 Citations |
| 1 | Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4. (Mysinger MM, Weiss DR, Ziarek JJ, Gravel S, Doak AK, Karpiak J, Heveker N, Shoichet BK, Volkman BF) Proc Natl Acad Sci U S A 2012 Apr 03;109(14):5517-22 123 Citations |
| 1 | Signaling through L-selectin mediates enhanced chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine. (Subramanian H, Grailer JJ, Ohlrich KC, Rymaszewski AL, Loppnow JJ, Kodera M, Conway RM, Steeber DA) J Immunol 2012 Apr 01;188(7):3223-36 32 Citations |
| 3 | Sequence-specific recruitment of heterochromatin protein 1 via interaction with Krüppel-like factor 11, a human transcription factor involved in tumor suppression and metabolic diseases. (Lomberk G, Mathison AJ, Grzenda A, Seo S, DeMars CJ, Rizvi S, Bonilla-Velez J, Calvo E, Fernandez-Zapico ME, Iovanna J, Buttar NS, Urrutia R) J Biol Chem 2012 Apr 13;287(16):13026-39 45 Citations |
| 1 | Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling. (Malik R, Soh UJ, Trejo J, Marchese A) J Biol Chem 2012 Mar 16;287(12):9013-27 35 Citations |
| 1 | Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction. (Saini V, Marchese A, Tang WJ, Majetschak M) J Biol Chem 2011 Dec 23;286(51):44145-44152 34 Citations |
| 2 | Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. (Drury LJ, Ziarek JJ, Gravel S, Veldkamp CT, Takekoshi T, Hwang ST, Heveker N, Volkman BF, Dwinell MB) Proc Natl Acad Sci U S A 2011 Oct 25;108(43):17655-60 160 Citations |
| 2 | The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions. (Saini V, Staren DM, Ziarek JJ, Nashaat ZN, Campbell EM, Volkman BF, Marchese A, Majetschak M) J Biol Chem 2011 Sep 23;286(38):33466-77 77 Citations |
| 1 | Ubiquitination of GPCRs. (Caballero A, Marchese A) Methods Mol Biol 2011;746:251-9 5 Citations |
| 2 | Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular-regulated kinase-1/2 in restitution. (Zimmerman NP, Vongsa RA, Faherty SL, Salzman NH, Dwinell MB) Lab Invest 2011 Jul;91(7):1040-55 26 Citations |
| 1 | Evaluation of nuclear factor κB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610. (Okera M, Bae K, Bernstein E, Cheng L, Lawton C, Wolkov H, Pollack A, Dicker A, Sandler H, Sweeney CJ) BJU Int 2011 Jul;108(2 Pt 2):E51-8 17 Citations |
| 1 | Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. (Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, Bi FC, Hamel DJ, Kuhn P, Handel TM, Cherezov V, Stevens RC) Science 2010 Nov 19;330(6007):1066-71 1463 Citations |
| 1 | Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CXCR4. (Malik R, Marchese A) Mol Biol Cell 2010 Jul 15;21(14):2529-41 75 Citations |
| 2 | Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design. (Veldkamp CT, Ziarek JJ, Peterson FC, Chen Y, Volkman BF) J Am Chem Soc 2010 Jun 02;132(21):7242-3 61 Citations |
| 1 | Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers. (Agle KA, Vongsa RA, Dwinell MB) J Biol Chem 2010 May 21;285(21):16066-75 46 Citations |
| 1 | CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin. (Saini V, Marchese A, Majetschak M) J Biol Chem 2010 May 14;285(20):15566-15576 135 Citations |
| 1 | Brucella melitensis, B. neotomae and B. ovis elicit common and distinctive macrophage defense transcriptional responses. (Covert J, Mathison AJ, Eskra L, Banai M, Splitter G) Exp Biol Med (Maywood) 2009 Dec;234(12):1450-67 27 Citations |
| 1 | Ubiquitination of chemokine receptors. (Marchese A) Methods Enzymol 2009;460:413-22 13 Citations |
| 1 | The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction. (Bhandari D, Robia SL, Marchese A) Mol Biol Cell 2009 Mar;20(5):1324-39 69 Citations |
| 1 | Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association. (Vera PL, Iczkowski KA, Wang X, Meyer-Siegler KL) PLoS One 2008;3(12):e3898 37 Citations |
| 2 | Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases. (Seibert C, Veldkamp CT, Peterson FC, Chait BT, Volkman BF, Sakmar TP) Biochemistry 2008 Oct 28;47(43):11251-62 64 Citations |
| 2 | Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. (Veldkamp CT, Seibert C, Peterson FC, De la Cruz NB, Haugner JC 3rd, Basnet H, Sakmar TP, Volkman BF) Sci Signal 2008 Sep 16;1(37):ra4 245 Citations |
| 1 | Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients. (Mosadegh B, Saadi W, Wang SJ, Jeon NL) Biotechnol Bioeng 2008 Aug 15;100(6):1205-13 62 Citations |
| 1 | Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. (Bhandari D, Trejo J, Benovic JL, Marchese A) J Biol Chem 2007 Dec 21;282(51):36971-9 161 Citations |
| 1 | Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. (Wendt MK, Cooper AN, Dwinell MB) Oncogene 2008 Feb 28;27(10):1461-71 102 Citations |
| 1 | Rho activation regulates CXCL12 chemokine stimulated actin rearrangement and restitution in model intestinal epithelia. (Moyer RA, Wendt MK, Johanesen PA, Turner JR, Dwinell MB) Lab Invest 2007 Aug;87(8):807-17 67 Citations |
| 1 | CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4. (Slagsvold T, Marchese A, Brech A, Stenmark H) EMBO J 2006 Aug 23;25(16):3738-49 58 Citations |
| 1 | Assessment of degradation and ubiquitination of CXCR4, a GPCR regulated by EGFR family members. (Marchese A) Methods Mol Biol 2006;327:139-45 8 Citations |
| 2 | Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12). (Veldkamp CT, Seibert C, Peterson FC, Sakmar TP, Volkman BF) J Mol Biol 2006 Jun 23;359(5):1400-9 103 Citations |
| 1 | AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. (Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P) Blood 2006 May 01;107(9):3772-8 169 Citations |
| 1 | Lack of susceptibility of cells from patients with Fabry disease to productive infection with R5 human immunodeficiency virus. (Lund N, Branch DR, Sakac D, Lingwood CA, Siatskas C, Robinson CJ, Brady RO, Medin JA) AIDS 2005 Sep 23;19(14):1543-6 31 Citations |
| 1 | A new key in breast cancer metastasis. (Benovic JL, Marchese A) Cancer Cell 2004 Nov;6(5):429-30 35 Citations |
| 1 | CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity. (Smith JM, Johanesen PA, Wendt MK, Binion DG, Dwinell MB) Am J Physiol Gastrointest Liver Physiol 2005 Feb;288(2):G316-26 75 Citations |
| 1 | Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells. (Heidemann J, Ogawa H, Rafiee P, Lügering N, Maaser C, Domschke W, Binion DG, Dwinell MB) Am J Physiol Gastrointest Liver Physiol 2004 Jun;286(6):G1059-68 65 Citations |
| 1 | SDF-1/CXCL12 regulates cAMP production and ion transport in intestinal epithelial cells via CXCR4. (Dwinell MB, Ogawa H, Barrett KE, Kagnoff MF) Am J Physiol Gastrointest Liver Physiol 2004 May;286(5):G844-50 40 Citations |
| 1 | The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. (Marchese A, Raiborg C, Santini F, Keen JH, Stenmark H, Benovic JL) Dev Cell 2003 Nov;5(5):709-22 320 Citations |
| 1 | Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. (Oh SB, Tran PB, Gillard SE, Hurley RW, Hammond DL, Miller RJ) J Neurosci 2001 Jul 15;21(14):5027-35 403 Citations |
| 1 | Chemokine receptor expression by human intestinal epithelial cells. (Dwinell MB, Eckmann L, Leopard JD, Varki NM, Kagnoff MF) Gastroenterology 1999 Aug;117(2):359-67 182 Citations |
| 1 | Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. (Michael NL, Nelson JA, KewalRamani VN, Chang G, O'Brien SJ, Mascola JR, Volsky B, Louder M, White GC 2nd, Littman DR, Swanstrom R, O'Brien TR) J Virol 1998 Jul;72(7):6040-7 168 Citations |
© 2023 Clinical & Translational Science Institute